Metformin enhances the cytotoxic effect of nilotinib and overcomes nilotinib resistance in chronic myeloid leukemia cells
Author:
Funder
Brain Korea
Publisher
Korean Association of Internal Medicine
Link
http://kjim.org/upload/kjim-2019-336.pdf
Reference27 articles.
1. Chromosome Abnormalities in Malignant Hematologic Diseases
2. Oncogene Activation by Chromosomal Translocation in Chronic Myelocytic Leukemia
3. The molecular biology of chronic myeloid leukemia
4. Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL
5. Incidence of type 2 diabetes mellitus and hyperlipidemia in patients prescribed dasatinib or nilotinib as first- or second-line therapy for chronic myelogenous leukemia in the US
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Nilotinib Exerts a Therapeutic Approach via JAK/STAT Pathway and Cytokine Network in Chronic Myeloid Leukemia Cells;Ege Tıp Dergisi;2024-03-19
2. Nilotinib exhibits less toxicity than imatinib and influences the immune state by modulating iNOS, p-p38 and p-JNK in LPS/IFN gamma-activated macrophages;Toxicology in Vitro;2024-03
3. Research Progress on the Use of Metformin in Leukemia Treatment;Current Treatment Options in Oncology;2024-01-30
4. Identification and overcoming rituximab resistance in diffuse large B-cell lymphoma using next-generation sequencing;The Korean Journal of Internal Medicine;2023-11-01
5. Repurposing Metformin in hematologic tumor: State of art;Current Problems in Cancer;2023-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3